B&H Case Study: Helping B-Complex Tablets Enter the Southeast Asia Market in Just Six Months

As the global nutrition and health market undergoes structural transformation, Southeast Asia — powered by population growth and rising consumer demand — has emerged as a new blue ocean for China’s health supplement exports. For many OEM manufacturers, the competition now centers on one question: how to complete product initiation, formulation development, regulatory filing, and market entry in the shortest possible time.

Recently, B&H announced a successful case in which it helped an international brand client complete the full export process of B-complex tablets to Southeast Asia within six months — achieving efficient transformation from R&D to market launch. The project has since become a benchmark example of OEM supplement export excellence.

Market Landscape: Southeast Asia Becomes the New Battleground for Functional Tablets
According to Euromonitor, the Southeast Asian health supplement market is projected to exceed USD 12 billion by 2026, with B-complex and multivitamin tablets accounting for over 30% of total sales. Energy-boosting products featuring B vitamins are among the fastest-growing categories.

However, the region’s regulatory landscape remains complex and fragmented. For example, Malaysia and Thailand require comprehensive ingredient dossiers and label reviews for all imported supplements, while Indonesia mandates that foreign brands appoint a local regulatory representative. For companies with limited export experience, these requirements often lead to delays or rejections due to incomplete documentation or noncompliant formulations.

B&H’s Integrated OEM Solution: From Concept to Compliance
From project kickoff to final shipment, B&H provided a fully integrated OEM service, offering an end-to-end solution covering formulation design, regulatory compliance, production, and international logistics.

Market-Oriented Formulation Development
The B&H R&D team customized the formulation to match Southeast Asian nutritional profiles, enhancing the ratio of B vitamins and essential minerals while incorporating natural plant extracts to align with the region’s growing preference for “Clean Label” formulations among younger consumers.

Regulatory Filing and Documentation
To meet the stringent requirements of Indonesia’s BPOM and Singapore’s HSA, B&H developed a standardized export documentation package, enabling the client to prepare complete regulatory materials within 45 days and secure early market entry opportunities.

GMP Manufacturing and Quality Assurance
All B-complex tablets were manufactured at B&H’s international GMP-certified facility, implementing a strict batch traceability and stability testing system. Each batch was accompanied by a Certificate of Analysis (COA) and stability report, ensuring compliance with local storage and distribution standards across Southeast Asia.

International Logistics and Customs Coordination
Through its partnership network of cross-border logistics providers, B&H implemented an optimized air-sea combined transport model from Guangzhou to Singapore, reducing the average customs clearance cycle to seven days—about 40% faster than conventional OEM export processes.

Results and Client Feedback
The client’s first batch of B-complex tablets was officially launched in Singapore in July 2025, achieving strong sales performance across pharmacies and e-commerce platforms thanks to its high purity and product stability.

The client commented:
“B&H doesn’t just provide manufacturing — they deliver complete regulatory and market-entry support that enables brands to localize rapidly and confidently.”

Following the project’s success, the client signed a long-term partnership agreement with B&H, adding three additional products to its OEM production pipeline to further expand its footprint in the Southeast Asian supplement market.

Industry Impact: Compliance as the Core of Global Competitiveness

The capabilities B&H demonstrated in this project go beyond formulation and production. Its true strength lies in regulatory integration — the ability to tailor compliance strategies for each target market.

B&H’s “compliance-by-design” approach helps clients identify restricted ingredients, manage label claims, and avoid regulatory risks as early as the formulation stage.

This forward-looking philosophy is rapidly becoming the new standard for the next generation of supplement OEM manufacturing.

Looking Ahead: Accelerating the Globalization of Chinese Nutrition Brands

Southeast Asia is becoming a strategic stronghold for global supplement brands. OEM manufacturers like B&H, with extensive experience in international registration and tablet formulation, are emerging as key partners for global expansion.

Going forward, B&H will continue to strengthen its OEM capabilities across B-complex tablets, softgels, and powdered supplements, building a collaborative ecosystem that integrates R&D, regulatory compliance, and export solutions.

Through this integrated model, B&H aims to empower more clients to transition from “Made in China” to “Globally Recognized Nutrition Brands.”